Corium International, Inc.
DelistedCIK 1594337fmd_1Y2210HQMP2G76V1Q5NCZ19ARWManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Oct 01, 2011 to Jun 30, 2018, 24 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|---|
| Total revenues | 43 | 50 | 42 | 41 | 33 | 32 |
| Cost of revenue | 24 | 25 | 20 | 18 | 17 | 15 |
| Gross profit | 19 | 25 | 22 | 23 | 16 | 17 |
| Research and development | 4 | 5 | 7 | 16 | 22 | 32 |
| Operating income | (1) | 1 | (10) | (21) | (29) | (40) |
| Interest expense | 5 | 8 | 7 | 7 | 8 | 8 |
| Income before taxes | (5) | (14) | (10) | (28) | (37) | (48) |
| Income tax expense | (0) | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (5) | (14) | (10) | (28) | (37) | (48) |
| Net income | (5) | (14) | (10) | (28) | (37) | (48) |
| Net income to common shareholders | (5) | (14) | (10) | – | – | – |